Label-Free Quantitative Proteomic Profiling Identifies Potential Active Components to Exert Pharmacological Effects in the Fruit of Alpinia oxyphylla by Mass Spectrometry

다국어 초록 (Multilingual Abstract)

To explore the relationship between fruit developmental periods and the protein datasets of Alpinia oxyphylla, a label-free quantitative proteomic profiling analysis of the A. oxyphylla fruits sampled at the Earlystage, Metaphase and Advanced stage was carried out using the liquid chromatography combined with tandem mass spectrometry. A total of 19,219 peptide fragments and 4946 quantitative proteins were obtained. Annotation and enrichment analysis of these peptides and proteins were performed using the Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) databases with bioinformatics software. The results showed that the differentially expressed proteins were mainly involved in metabolic and cellular processes, cellular component organization or biogenesis and response to the stimulus. Three significantly enriched metabolic pathways were non-alcoholic fatty liver disease, vibrio cholera infection and valine, leucine and isoleucine degradation. The significantly enriched proteins were NADH dehydrogenase, putative vacuolar proton translocation ATPase and putative acyltransferase component. The proteomic profiles of the fruit samples from the Advanced and the Metaphase stages differed little, while the difference in proteomic components between the Earlystage and the Advanced groups was significant. This study should lay the theoretical foundation for the effective utilization of A. oxyphylla germplasm resource in the treatment of human diseases.

참고문헌 (Reference)

1 Wiśniewski JR, "Universal sample preparation method for proteome analysis" 6 (6): 359-362, 2009

2 Bian QY, "Two new antioxidant diarylheptanoids from the fruits of Alpinia oxyphylla" 15 (15): 1094-1099, 2013

3 Zabala G, "Transcriptome changes in the phenylpropanoid pathway of Glycine max in response to Pseudomonas syringae infection" 6 (6): 26-, 2006

4 Dixon RA, "The phenylpropanoid pathway and plant defense-a genomics perspective" 3 (3): 371-390, 2002

5 Patra KC, "The pentose phosphate pathway and cancer" 39 (39): 347-354, 2014

6 Kindt E, "The need of essential amino acids in children : an evaluation based on the intake of phenylalanine, tyrosine, leucine, isoleucine, and valine in children with phenylketonuria, tyrosine amino transferase defect, and maple syrup urine disease" 33 (33): 279-286, 1980

7 Gao B, "The complete chloroplast genome sequence of Alpinia oxyphylla Miq. and comparison analysis within the Zingiberaceae family" 14 (14): e0218817-, 2019

8 Youle RJ, "The BCL-2 protein family : opposing activities that mediate cell death" 9 : 47-59, 2008

9 Esposito G, "Synaptic vesicle trafficking and Parkinson’s disease" 72 (72): 134-144, 2011

10 Lee E, "Suppression of mouse skin tumor promotion and induction of apoptosis in HL-60 cells by Alpinia oxyphylla Miquel(Zingiberaceae)" 19 (19): 1377-1381, 1998

11 Kubo M, "Study on Alpiniae Fructus. I. Pharmacological evidence of efficacy of Alpiniae Fructus on ancient herbal literature" 115 : 852-862, 1995

12 Zhao X, "Simultaneous determination of chrysin and tectochrysin from Alpinia oxyphylla fruits by UPLC-MS/MS and its application to a comparative pharmacokinetic study in normal and dementia rats" 23 : 1702-, 2018

13 Taheri P, "Riboflavin induces resistance in rice against Rhizoctonia solani via jasmonate-mediated priming of phenylpropanoid pathway" 167 (167): 201-208, 2010

14 Li XZ, "Recent advances in herbal medicines treating Parkinson’s disease" 84 : 273-285, 2013

15 Sun Z, "Rapid extraction and determination of 25 bioactive constituents in Alpinia oxyphylla using microwave extraction with ultra-high performance liquid chromatography with tandem mass spectrometry" 39 (39): 603-610, 2016

16 Zhu X, "Quantitative analysis of global proteome and lysine acetylome reveal the differential impacts of VPA and SAHA on HL60 cells" 6 : 19926-, 2016

17 An LJ, "Protocatechuic acid from Alpinia oxyphylla against MPP+-induced neurotoxicity in PC12cells" 44 (44): 436-443, 2006

18 Koo BS, "Protective effects of Alpinae oxyphyllae fructus(Alpinia oxyphylla MIQ)waterextracts on neurons from ischemic damage and neuronal cell toxicity" 18 (18): 142-148, 2004

19 Shi SH, "Protective effect of n-butanol extract from Alpinia oxyphylla on learning and memory impairments" 139 : 13-20, 2015

20 Vogt T, "Phenylpropanoid biosynthesis" 3 : 2-20, 2010

21 Pharmacopoeia Committee, "Pharmacopoeia of the People’s Republic of China, vol I" Chemical Industry Press 104-, 2005

22 Xu J, "Pharmacological mechanisms underlying the neuroprotective effects of Alpinia oxyphylla Miq. on Alzheimer’s disease" 21 : 2071-, 2020

23 Mok CC, "Pathogenesis of systemic lupus erythematosus" 56 : 481-490, 2003

24 Zhang SH, "Novel metabolic and physiological functions of branched chain amino acids : a review" 8 : 10-, 2017

25 Hou L, "New sesquiterpenoids and a diterpenoid from Alpinia oxyphylla" 20 : 1551-1559, 2015

26 Jiang B, "New eudesmane sesquiterpenes from Alpinia oxyphylla and determination of their inhibitory effects on microglia" 23 (23): 3879-3883, 2013

27 Yu XY, "Neuroprotective effect of Alpinia oxyphylla Miq. fruits against glutamate-induced apoptosis in cortical neurons" 14 : 205-212, 2003

28 Zhao XS, "Multi-elements determination in medical and edible Alpinia oxyphylla and Morinda officinalis and their decoctions by ICP-MS" 164 : 430-435, 2016

29 Xu JZ, "MicroRNAs in autophagy and their emerging roles in crosstalk with apoptosis" 8 (8): 873-882, 2012

30 Dixon RA, "Metabolic engineering : prospects for crop improvement through the genetic manipulation of phenylpropanoid biosynthesis and defense responses-a review" 179 (179): 61-71, 1996

31 Cox J, "MaxQuant enables high peptide identification rates, individualized p.p.b. range mass accuracies and proteomewide protein quantification" 26 (26): 1367-1372, 2008

32 Batelli S, "Macroautophagy and the proteasome are differently involved in the degradation of alpha-synuclein wild type and mutated A30P in an in vitro inducible model(PC12/TetOn)" 195 : 128-137, 2011

33 Kanehisa M, "KEGG for integration and interpretation of largescale molecular data sets" 40 (40): D109-D114, 2012

34 Chapman MA, "Interactions between cell adhesion and the synaptic vesicle cycle in Parkinson’s disease" 83 (83): 203-207, 2014

35 Chang YM, "Inhibitory effect of alpinate Oxyphyllae fructus extracts on Ang II-induced cardiac pathological remodeling-related pathways in H9c2 cardiomyoblast cells" 3 : 148-152, 2013

36 Xu JJ, "Inhibitory activity of eudesmane sesquiterpenes from Alpinia oxyphylla on production of nitric oxide" 22 (22): 1660-1663, 2012

37 Khodaei H, "Inhibition of IL-4 but not IFN-γproduction by splenocytes of mice immunized with ovalbumin after oral administration of 5-hydroxymethylfurfural" 28 (28): 27-34, 2017

38 Wang CZ, "In vitro antioxidant and cytotoxic properties of ethanol extract of Alpinia oxyphylla fruits" 51 (51): 1419-1425, 2013

39 Götz S, "Highthroughput functional annotation and data mining with the Blast2GO suite" 36 (36): 3420-3435, 2008

40 Ashburner M, "Gene ontology: tool for the unification of biology. The Gene Ontology Consortium" 25 (25): 25-29, 2000

41 Miao Q, "GC-FID coupled with chemometrics for quantitative and chemical fingerprinting analysis of Alpinia oxyphylla oil" 102 : 436-442, 2015

42 Lv XQ, "Four new sesquiterpenoids from the fruits of Alpinia oxyphylla" 59 (59): 402-406, 2011

43 Zhang Q, "Ethnopharmacological uses, phytochemistry, biological activities, and therapeutic applications of Alpinia oxyphylla Miquel : a review" 224 : 149-168, 2018

44 Zhang Z, "Ethanolic extract of fructus Alpinia oxyphylla protects against 6-hydroxydopamine-induced damage of PC12cells in vitro and dopaminergic neurons in zebrafish" 32 : 27-40, 2012

45 Weiss H, "EJB reviews 1991" Springer 1991

46 Li YH, "Diuretic and anti-diuretic bioactivity of the seed and shell extracts of Alpinia oxyphylla fruit" 13 (13): 25-32, 2016

47 Ebrahimi-Fakhari D, "Distinct roles in vivo for the ubiquitin-proteasome system and the autophagylysosomal pathway in the degradation of alpha-synuclein" 31 : 14508-14520, 2011

48 Li GH, "Discovery, synthesis, and functional characterization of a novel neuroprotective natural product from the fruit of Alpinia oxyphylla for use in Parkinson’s disease through LC/MS-based multivariate data analysis-guided fractionation" 15 (15): 2595-2606, 2016

49 Chen F, "Different accumulation profiles of multiple components between pericarp and seed of Alpinia oxyphylla capsular fruit as determined by UFLC-MS/MS" 19 : 4510-4523, 2014

50 Fang JY, "Development of sesquiterpenes from Alpinia oxyphylla as novel skin permeation enhancers" 19 : 253-262, 2003

51 Lee HJ, "Clearance of alphasynuclein oligomeric intermediates via the lysosomal degradation pathway" 24 : 1888-1896, 2004

52 Song WJ, "Characterization of nucleobases and nucleosides in the fruit of Alpinia oxyphylla collected from different cultivation regions" 6 (6): 239-245, 2014

53 Calder PC, "Branched-chain amino acids and immunity" 136 (136): 288-, 2006

54 Yan TX, "Brainderived neurotrophic factor signaling mediates the antidepressant-like effect of the total flavonoids of Alpiniae oxyphyllae Fructus in chronic unpredictable mild stress mice" 30 : 1493-1502, 2016

55 Lin RJ, "Antioxidant, anti-adipocyte differentiation, antitumor activity and anthelmintic activities against Anisakis simplex and Hymenolepis nana of yakuchinone A from Alpinia oxyphylla" 13 : 237-, 2013

56 Wang S, "Antidiarrheal effect of Alpinia oxyphylla Miq. (Zingiberaceae) in experimental mice and its possible mechanism of action" 168 : 182-190, 2015

57 He ZH, "Antiangiogenic effects of the fruit of Alpinia oxyphylla" 132 : 443-449, 2010

58 Zhang Q, "Anti-proliferative and pro-apoptotic activities of Alpinia oxyphylla on HepG2 cells through ROS-mediated signaling pathway" 169 : 99-108, 2015

59 Zhang JQ, "Anti-diarrheal constituents of Alpinia oxyphylla" 89 : 149-156, 2013

60 Cox J, "Andromeda : a peptide search engine integrated into the MaxQuant environment" 10 (10): 1794-1805, 2011

61 Wang HY, "Analysis of the genetic diversity of natural populations of Alpinia oxyphylla Miquel using inter-simple sequence repeat markers" 52 : 1767-1775, 2012

62 Li YH, "Analysis of nine compounds from Alpinia oxyphylla fruit at different harvest time using UFLC-MS/MS and an extraction method optimized by orthogonal design" 7 : 134-, 2013

63 Wang MS, "Ameliorating effect of Alpinia oxyphylla-Schisandra chinensis herb pair on cognitive impairment in a mouse model of Alzheimer’s disease" 97 (97): 128-135, 2018

64 Xie Y, "Alpinia oxyphylla Miq. extract prevents diabetes in mice by modulating gut microbiota" 2018 : 1-10, 2018

65 Sang SG, "Alpinia oxyphylla Miq. extract changes microRNA expression profiles in db-/db-mouse lives" 10 (10): 14447-14457, 2017

66 Chang YM, "Alpinia oxyphylla Miq. Fruit extract activates IGFR-PI3K/Akt signaling to induce Schwann cell proliferation and sciatic nerve regeneration" 17 (17): 84-, 2017

67 Chuan-Te Tsai, "Alpinate Oxyphyllae Fructus Inhibits IGFII-Related Signaling Pathway to Attenuate Ang II-Induced Pathological Hypertrophy in H9c2 Cardiomyoblasts" 한국식품영양과학회 19 (19): 300-309, 2016

68 Cox J, "Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ" 13 (13): 2513-2526, 2014

69 Tewari A, "A review on Alpinia species : chemical, biocidal and pharmacological aspects" 21 : 1155-1168, 1999

70 Liu AJ, "5-hydroxymethylfurfural, an antioxidant agent from Alpinia oxyphylla Miq. Improves cognitive impairment in Aβ1-42 mouse model of Alzheimer′s disease" 23 : 719-725, 2014